IOVA ▲ +3.8% - Iovance Biotherapeutics, Inc. $IOVA U.S. Amtagvi revenue $102M. ↑ 77% YoY On track to achieve the guidance range of $410M to $420M in total product revenue in 2026. 05-NOV-2026 07:03 AM ET